Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pathologic Complete Response 1Nasopharyngeal Carcinoma 1

Interventions

pembrolizumab 133Carboplatin 132Cisplatin 121Paclitaxel 105Gemcitabine 91Specimen Handling 82Magnetic Resonance Spectroscopy 82Docetaxel 74Dexamethasone 62Cyclophosphamide 60Pemetrexed 58Capecitabine 56Bevacizumab 56durvalumab 54Oxaliplatin 51Radiotherapy 50Doxorubicin 50Fluorouracil 49Radiation 46Leucovorin 44Rituximab 43Lenalidomide 42Vincristine 40Etoposide 38Nivolumab 37atezolizumab 36Letrozole 35130-nm albumin-bound paclitaxel 33Irinotecan 31Prednisone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Induction Chemotherapy × 90 days × Clear all
NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Sun Yat-sen University

Phase 3 Recruiting
380 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡